Sale of 3rd Tranche of Exempt Offer Bond Programme
Source: RNSTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 (INCLUDING AS IT FORMS PART OF THE LAWS OF ENGLAND AND WALES BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR").
15 February 2024
Ferro-Alloy Resources Limited
("Ferro-Alloy" or the "Group" or the "Company")
Sale of Third Tranche of Exempt Offer Bond Programme
Ferro-Alloy Resources Limited (LSE:FAR), the vanadium producer and developer of the large Balasausqandiq vanadium deposit in Southern Kazakhstan, is pleased to announce the sale of all bonds issued under the US$5m third tranche (the "Third Tranche") of the Kazakhstan exempt offer bond programme (the "Programme").
Background
As previously announced, the Company listed the Third Tranche of bonds under the Programme on 30 January 2024, for the development of the Balasausqandiq project including front-end engineering.
The nominal value of the Third Tranche was US$5m, with a nominal coupon rate of 11%, payable quarterly, and a two and a half year maturity.
Sale / Proceeds
All bonds listed under the Third Tranche have been sold and net proceeds of US$4.73m have now been received by the Company.
Summary
The three tranches of bonds issued and listed under the Programme to date have been sold, in aggregate, for US$13m. Under the terms of the Programme, US$7m of headroom remains for the issue of future tranches by the Company.
For further information, visit www.ferro-alloy.com or contact:
Ferro-Alloy Resources Limited |
Nick Bridgen (CEO) / William Callewaert (CFO) |
info@ferro-alloy.com
|
Freedom Finance Global PLC (Bond Underwriter)
|
Renat Syzdykov |
+7 701 766 4865 / ib@ffin.kz |
Shore Capital (Joint Corporate Broker)
Liberum Capital Limited (Joint Corporate Broker) |
Toby Gibbs/Lucy Bowden
Scott Mathieson/John More
|
+44 207 408 4090
+44 20 3100 2000
|
St Brides Partners Limited (Financial PR & IR Adviser) |
Ana Ribeiro/Zoe Briggs |
+44 207 236 1177 |
About Ferro-Alloy Resources Limited:
The Company's operations are all located at the Balasausqandiq deposit in Kyzylordinskoye Oblast in the South of Kazakhstan. Currently the Company has two main business activities:
a) the high grade Balasausqandiq vanadium project (the "Project"); and
b) an existing vanadium concentrate processing operation (the "Existing Operation")
Balasausqandiq is a very large deposit, with vanadium as the principal product together with several by-products. Owing to the nature of the ore, the capital and operating costs of development are very much lower than for other vanadium projects.
The most recent mineral resource estimate for ore-body one (of seven) provided an Indicated Mineral Resource of 32.9 million tonnes at a mean grade of 0.62% V2O5 equating to 203,364 contained tonnes of vanadium pentoxide ("V2O5"). In the system of reserve estimation used in Kazakhstan the reserves are estimated to be over 70m tonnes in ore-bodies 1 to 5 but this does not include the full depth of ore-bodies 2 to 5 or the remaining ore-bodies which remain substantially unexplored.
The Project will be developed in two stages, Stage 1 and Stage 2, treating 1m tonnes per year and an additional 3m tonnes per year. Production will be some 5,600 tonnes of V2O5 from Stage 1, rising to 22,400 tonnes V2O5 after Stage 2 is commissioned.
There is an existing concentrate processing operation at the site of the Balasausqandiq deposit. The production facilities were originally created from a 15,000 tonnes per year pilot plant which was then expanded and adapted to recover vanadium, molybdenum and nickel from purchased concentrates.
The existing operation is located on the same site and uses some of the same infrastructure as the Project, but is a separate operation which will continue in parallel with the development and operation of the Project.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.